Maintaining organ viability after donation until transplantation is critically important for
optimal graft function and survival. To date, static cold storage is the most widely used form …

Fridell JA, Rogers J, Stratta RJ. The pancreas allograft donor: current status, controversies,
and challenges for the future. Clin Transplant 2010: 24: 433–449.© 2010 John Wiley & Sons …

Organ transplantation remains the only life-saving therapy for many patients with organ
failure. Despite the work of the Organ Donation and Transplant Collaboratives, and the …

Histidine‐tryptophan‐ketoglutarate solution (HTK) and University of Wisconsin solution (UW)
have been shown to have similar outcomes in cadaveric kidney, pancreas, and liver …

Liver, pancreas, and kidney allografts preserved in histidine‐tryptophan‐ketoglutarate (HTK)
and University of Wisconsin (UW) solutions have similar clinical outcomes. This study …

Ischemia-reperfusion injury (IRI) results in increased rates of delayed graft function and early
graft loss. It has recently been reported that hydrogen sulfide (H 2 S) protects organ grafts …

Prior single-center studies have reported that pancreas allograft survival is not affected by
preservation in histidine-tryptophan-ketoglutarate (HTK) versus University of Wisconsin …

Microencapsulation may allow for immunosuppression-free islet transplantation. Herein we
investigated whether human islets can be shipped safely to a remote encapsulation core …

Cold storage may be adequate for preservation before pancreas transplants, but insufficient
when pancreases are processed for islets or when expanded donors are used …

We aimed to evaluate early pancreas transplant graft function after histidine–tryptophan–
ketoglutarate (HTK) versus University of Wisconsin (UW) perfusion. Prospective randomized …